Compounds > 1-beta-d-arabinofuranosylcytosine 5'-monophosphate
Page last updated: 2024-08-24

1-beta-d-arabinofuranosylcytosine 5'-monophosphate and Sarcoma, Kaposi

1-beta-d-arabinofuranosylcytosine 5'-monophosphate has been researched along with Sarcoma, Kaposi in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hernández, DE; Pellino, ML; Ramírez, B1

Other Studies

1 other study(ies) available for 1-beta-d-arabinofuranosylcytosine 5'-monophosphate and Sarcoma, Kaposi

ArticleYear
Acute myelocytic leukaemia associated with Kaposi's sarcoma in a patient without serum antibodies to human immunodeficiency virus type 1.
    The British journal of dermatology, 1996, Volume: 134, Issue:3

    Topics: Adult; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; HIV Antibodies; HIV-1; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Sarcoma, Kaposi

1996